|
ROMAN: Phase 3 trial of avasopasem manganese (GC4419) for severe oral mucositis (SOM) in patients receiving chemoradiotherapy (CRT) for locally advanced, nonmetastatic head and neck cancer (LAHNC). |
|
|
Employment - University of Iowa Hospitals and Clinics; University of Iowa Hospitals and Clinics (I) |
Research Funding - Galera Therapeutics (Inst); Soligenix (Inst) |
(OPTIONAL) Uncompensated Relationships - Galera Therapeutics |
|
|
Employment - Cancer Care Northwest; Gamma Knife of Spokane |
Stock and Other Ownership Interests - Axcend LLC; Kobold |
Honoraria - Bayer; Bristol-Myers Squibb; Lilly; Merck |
Consulting or Advisory Role - Bayer; Elekta |
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Lilly; Merck |
Research Funding - Galera Therapeutics (Inst) |
Patents, Royalties, Other Intellectual Property - Axcend LLC; Gamma Knife Spokane; Kobold |
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Elekta; Lilly; Merck |
|
|
|
Research Funding - Galera Therapeutics (Inst) |
|
|
Research Funding - Galera Therapeutics (Inst) |
|
|
Research Funding - Galera Therapeutics (Inst) |
|
|
No Relationships to Disclose |
|
|
Research Funding - Galera Therapeutics (Inst) |
|
|
Stock and Other Ownership Interests - Ensign Group; Galera Therapeutics; Novocure |
Research Funding - Galera Therapeutics (Inst) |
|
|
Stock and Other Ownership Interests - Galera Therapeutics |
|
|
|
Research Funding - Galera Therapeutics (Inst) |
|
|
Stock and Other Ownership Interests - AstraZeneca; CVS Health; Medtronic; Merck; Sanofi; Smith & Nephew; United Health Group |
Consulting or Advisory Role - Bayer |
Research Funding - Bayer (Inst); Galera Therapeutics (Inst); Merck (Inst); Sanofi (Inst) |
|
|
Research Funding - Galera Therapeutics (Inst) |
|
Amanda Lynn Gillespie-Twardy |
Research Funding - Galera Therapeutics (Inst) |
|
|
Employment - Biomodels; Primary Endpoint Solutions |
Leadership - Biomodels; Immunity Health; Primary Endpoint Solutions; Primary Endpoint Solutions |
Stock and Other Ownership Interests - BioInsight Diagnostics; Biomodels; Immunity Health; Inform Genomics |
Consulting or Advisory Role - Biomodels (Inst); Primary Endpoint Solutions (Inst) |
Research Funding - Biomodels (Inst); Primary Endpoint Solutions (Inst) |
Patents, Royalties, Other Intellectual Property - Predictive genomics (Inst); Raman spectropscopy |
|
|
Employment - Galera Therapeutics |
Leadership - Galera Therapeutics |
Stock and Other Ownership Interests - Galera Therapeutics |
|
|
Honoraria - AMGEN; Pfizer |
Consulting or Advisory Role - AFYX Therapeutics; AMGEN |
|
Travel, Accommodations, Expenses - Amgen |